Focusing on the particular ubiquitin ligases and deubiquitinating enzymes implicated in the cGAS-STING pathway presents a promising approach for the creation of therapeutics for autoimmune diseases, cancer, and viral infections, highlighting the necessity of investigating these interactions for novel therapeutic targets. Here, CGAS is linked to cancer.